Dedifferentiated thyroid cancer: A therapeutic challenge

This publication has 42 references indexed in Scilit:

• AKT in Thyroid Tumorigenesis and Progression
  Endocrinology, 2007
• Prevalence ofRET/PTCRearrangements in Thyroid Papillary Carcinomas: Effects of the Detection Methods and Genetic Heterogeneity
  Journal of Clinical Endocrinology & Metabolism, 2006
• Inhibitors of Raf Kinase Activity Block Growth of Thyroid Cancer Cells with RET/PTC or BRAF Mutations In vitro and In vivo
  Clinical Cancer Research, 2006
• Tyrosine Kinases as Targets for Cancer Therapy
  New England Journal of Medicine, 2005
• How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy
  Journal of Endocrinology, 2004
• Regulation of Signal Transducer and Activator of Transcription 1 (STAT1) and STAT1-Dependent Genes by RET/PTC (Rearranged in Transformation/Papillary Thyroid Carcinoma) Oncogenic Tyrosine Kinases
  Molecular Endocrinology, 2004
• Mutant ras-induced proliferation of human thyroid epithelial cells requires three effector pathways
  Oncogene, 2004
• Beyond Radioiodine: A Review of Potential New Therapeutic Approaches for Thyroid Cancer
  Journal of Clinical Endocrinology & Metabolism, 2003
• Expression of Angiogenesis Stimulators and Inhibitors in Human Thyroid Tumors and Correlation with Clinical Pathological Features
  The American Journal of Pathology, 1999
• Management of the patient with progressive radioiodine non-responsive disease
  Seminars in Surgical Oncology, 1999